|
Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Influenza
|
2012
|
NIAID
|
5R01AI043197-15
|
|
Alternative approaches for NALT-based immunity to respiratory pathogens
|
BOYAKA, PROSPER
|
OHIO STATE UNIVERSITY
|
OH
|
$367,538
|
Influenza
|
2012
|
NIGMS
|
5R01GM037188-23
|
|
Mucosal Cell Transporters and Enzymes for Enhancing Oral Drug Absorption
|
AMIDON, GORDON
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$374,010
|
Influenza
|
2012
|
NIAID
|
5R01AI051354-09
|
|
Regulation of Humoral Immunity to Influenza Virus
|
BAUMGARTH, NICOLE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$371,492
|
Influenza
|
2012
|
NHLBI
|
5R01HL091968-04
|
|
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
|
O'REILLY, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$381,150
|
Influenza
|
2012
|
NIAID
|
5R01AI011772-39
|
|
Replication of influenza virus
|
KRUG, ROBERT
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$689,912
|
Influenza
|
2012
|
NIAID
|
5R21AI092511-02
|
|
Regulation of dendritic cells by estrogen receptors during influenza infection
|
KOVATS, SUSAN
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$203,750
|
Influenza
|
2012
|
NIGMS
|
5R01GM068518-07
|
|
Super-resolution studies of the entry mechanisms of influenza viruses
|
ZHUANG, XIAOWEI
|
HARVARD UNIVERSITY
|
MA
|
$337,574
|
Influenza
|
2012
|
NIAID
|
5R01AI076499-05
|
|
Regulation of memory CD8+ T cell recruitment to the lung
|
BLACKMAN, MARCIA
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$460,647
|
Influenza
|
2012
|
NIAID
|
5R21AI092280-02
|
|
Development of a broadly neutralizing influenza virus vaccine
|
SCHNEEMANN, ANETTE
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$284,250
|
Influenza
|
2012
|
NIAID
|
5R44AI081396-03
|
|
Prodrugs of Neuraminidase Inhibitors for Increased Oral Bioavailability
|
HILFINGER, JOHN
|
TSRL, INC.
|
MI
|
$904,078
|
Influenza
|
2012
|
NIGMS
|
5R01GM095884-02
|
|
Pulmonary delivery of a hybrid therapeutic to halt respiratory viral infection
|
PHILLIPS, JOY
|
SAN DIEGO STATE UNIVERSITY
|
CA
|
$297,817
|
Influenza
|
2012
|
NIAID
|
5R03AI088449-02
|
|
Rational design of M2e-FP conserved epitope-based universal influenza A vaccines
|
DU, LANYING
|
NEW YORK BLOOD CENTER
|
NY
|
$81,000
|
Influenza
|
2012
|
FIC
|
5R03TW008739-02
|
|
Folding RNA: Influenza
|
TURNER, DOUGLAS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$55,393
|
Influenza
|
2012
|
NIGMS
|
2R01GM088204-03
|
|
Solid-state NMR of the influenza M2 protein in lipid bilayers
|
HONG, MEI
|
IOWA STATE UNIVERSITY
|
IA
|
$273,492
|
Influenza
|
2012
|
NIAID
|
5R01AI067839-04
|
|
Structural and Functional Study of Influenza Virus Hemagglutinin
|
WANG, QINGHUA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$300,891
|
Influenza
|
2012
|
NIMHD
|
5R24MD002754-06
|
|
Harlem Community Academic Partnership: Influenza Immunizations
|
VLAHOV, DAVID
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$575,514
|
Influenza
|
2012
|
NIGMS
|
1SC3GM099559-01
|
|
Influenza nucleoprotein interactions and viral RNA synthesis
|
NEWCOMB, LAURA
|
CALIFORNIA STATE UNIV SAN BERNARDINO
|
CA
|
$107,250
|
Influenza
|
2012
|
NIAID
|
5R44AI077112-04
|
|
SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES
|
DAWSON, ERICA
|
INDEVR, INC.
|
CO
|
$974,637
|
Influenza
|
2012
|
NINDS
|
5R01NS057395-05
|
|
Immunogenicity & efficacy of chimeric flu virus expressing Ab42 B cell epitope
|
AGADJANYAN, MICHAEL
|
INSTITUTE FOR MOLECULAR MEDICINE
|
CA
|
$373,999
|
Influenza
|
2012
|
NIGMS
|
1R01GM099989-01
|
|
Interplay of protein and membrane intermediates during influenza virus fusion
|
LEE, KELLY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$290,752
|
Influenza
|
2012
|
NIAID
|
5F32AI093087-02
|
|
Origin and Adaptation of Influenza-Specific Plasmablasts
|
ANDREWS, SARAH
|
UNIVERSITY OF CHICAGO
|
IL
|
$53,942
|
Influenza
|
2012
|
NIAID
|
5R01AI087879-03
|
|
Sortase-mediated protein engineering for the study of host-pathogen interactions
|
PLOEGH, HIDDE
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
MA
|
$482,625
|
Influenza
|
2012
|
NIAID
|
5R01AI093571-02
|
|
The Biology of Influenza A Virus-Generated Small RNAs
|
TENOEVER, BENJAMIN
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$420,547
|
Influenza
|
2012
|
NIAID
|
5K22AI091647-02
|
|
Defining the role of mast cells during influenza A virus infection
|
OBAR, JOSHUA
|
MONTANA STATE UNIVERSITY - BOZEMAN
|
MT
|
$108,000
|
Influenza
|
2012
|
NIAID
|
1R21AI098079-01
|
|
Immune factors in vaccine-enhanced pandemic H1N1 influenza disease
|
SANDBULTE, MATTHEW
|
IOWA STATE UNIVERSITY
|
IA
|
$185,000
|
Influenza
|
2012
|
NIAID
|
5R01AI080781-04
|
|
Novel vaccines for broad protection against avian influenza
|
ROSE, JOHN
|
YALE UNIVERSITY
|
CT
|
$405,516
|
Influenza
|
2012
|
NIAID
|
5R01AI091707-02
|
|
Type I interferon-stimulated genes and the antiviral immune response
|
RICE, CHARLES
|
ROCKEFELLER UNIVERSITY
|
NY
|
$422,500
|
Influenza
|
2012
|
NIAID
|
2R01AI078090-04
|
|
Risk of Influenza Infection In A Vaccinated Obese Population
|
BECK, MELINDA
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$592,709
|
Influenza
|
2012
|
NIAID
|
1R15AI094437-01A1
|
|
Role of influenza-induced prothrombosis in Streptococcus pyogenes superinfections
|
CHAUSSEE, MICHAEL
|
UNIVERSITY OF SOUTH DAKOTA
|
SD
|
$425,469
|
Influenza
|
2012
|
NHLBI
|
1R01HL107380-01A1
|
|
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia
|
ALCORN, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$372,570
|
Influenza
|
2012
|
NIAID
|
2R01AI040098-16
|
|
B lymphocyte Migration and Homeostasis
|
CYSTER, JASON
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$386,250
|
Influenza
|
2012
|
NCI
|
5R21CA157571-02
|
|
Health Outcomes, Risk Perceptions and Preventative Behavior on Social Networks
|
VARDAVAS, RAFFAELE
|
RAND CORPORATION
|
CA
|
$160,097
|
Influenza
|
2012
|
NIAID
|
5R01AI075219-05
|
|
Synthetic Viral Genome Design for Rapid Vaccine Development
|
WIMMER, ECKARD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$552,986
|
Influenza
|
2012
|
NIGMS
|
2R01GM061050-09A1
|
|
Structural Studies of Paramyxovirus fusion proteins
|
JARDETZKY, THEODORE
|
STANFORD UNIVERSITY
|
CA
|
$301,440
|
Influenza
|
2012
|
NIAID
|
1R21AI094133-01A1
|
|
Receptor tyrosine kinase signaling and influenza viral RNA synthesis
|
LIANG, YUYING
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$190,000
|
Influenza
|
2012
|
NIAID
|
5K01AI075089-05
|
|
Social Networks and the Spread of Influenza and other Nosocomial Infections
|
POLGREEN, PHILIP
|
UNIVERSITY OF IOWA
|
IA
|
$126,630
|
Influenza
|
2012
|
NIAID
|
1R03AI094193-01A1
|
|
Isolating Viral Particles from Whole Blood
|
HAYES, MARK
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$69,437
|
Influenza
|
2012
|
NIAID
|
1R21AI094185-01A1
|
|
RTB-mediated delivery: Orchestrating antigen trafficking to enhance cell immunity
|
CRAMER, CAROLE
|
ARKANSAS STATE UNIVERSITY
|
AR
|
$170,000
|
Influenza
|
2012
|
NIAID
|
1R43AI094891-01A1
|
|
Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes
|
JIMENEZ, GRETCHEN
|
MOLECULAR EXPRESS, INC.
|
CA
|
$300,000
|
Influenza
|
2012
|
NIAID
|
1F32AI096730-01A1
|
|
The Promotion of Inflammation by Bacterial Sialidases After Influenza Infection
|
BROWN, NICHOLAS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$55,670
|
Influenza
|
2012
|
NIAID
|
5K22AI091651-02
|
|
Elucidation of mechanisms that contribute to antigenic drift of influenza viruses
|
HENSLEY, SCOTT
|
WISTAR INSTITUTE
|
PA
|
$108,000
|
Influenza
|
2012
|
NIAID
|
5R01AI093348-02
|
|
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
|
CURTISS, ROY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$1,025,685
|
Influenza
|
2012
|
NIAID
|
5R01AI093772-03
|
|
Influenza vaccines inducing broadly cross protective immunity
|
KANG, SANG-MOO
|
GEORGIA STATE UNIVERSITY
|
GA
|
$413,221
|
Influenza
|
2012
|
NIAID
|
5R01AI089450-03
|
|
Receptor Mimics for Rapid Detection, Typing, and Susceptibility Testing of Influe
|
WEISS, ALISON
|
UNIVERSITY OF CINCINNATI
|
OH
|
$380,417
|
Influenza
|
2012
|
NIAID
|
5R01AI087846-03
|
|
Regulation of Host Innate Immunity Against Viral Infection
|
GACK, MICHAELA
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$386,471
|
Influenza
|
2012
|
OD
|
8K01OD010985-02
|
|
Role of Mkp-1 in pneumonia
|
WANCKET, LYN
|
OHIO STATE UNIVERSITY
|
OH
|
$129,087
|
Influenza
|
2012
|
NIAID
|
5U01AI082982-04
|
|
Alveolar type II cell innate immune response to influenza
|
MASON, ROBERT
|
NATIONAL JEWISH HEALTH
|
CO
|
$433,839
|
Influenza
|
2012
|
NIAID
|
5R01AI091797-02
|
|
Control of influenza virus by sphingolipid metabolism
|
HAHM, BUMSUK
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$364,762
|
Influenza
|
2012
|
NIAID
|
5U01AI082984-05
|
|
New Paradigms in Gene Regulation During Influenza Virus Infections
|
HORVATH, CURT
|
NORTHWESTERN UNIVERSITY
|
IL
|
$706,543
|
Influenza
|
2012
|
NIAID
|
5R21AI090359-02
|
|
Novel H1N1 influenza protection via cross-reactive immunity
|
DEGROOT, ANNE
|
EPIVAX, INC.
|
RI
|
$250,758
|
Influenza
|
2012
|
NIA
|
2P01AG021600-08A1
|
8596
|
Impact of Aging on CD4 Immunity to Flu
|
NO PI IDENTIFIED
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$340,998
|
Influenza
|
2012
|
NIA
|
2P01AG021600-08A1
|
8598
|
Impact of age on CD8+ T cell immunity to respiratory infection
|
WOODLAND, DAVID
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$387,823
|
Influenza
|
2012
|
NIA
|
2P01AG021600-08A1
|
8599
|
Impact of aging on the T cell repertoire and cellular immunity to influenza virus
|
BLACKMAN, MARCIA
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$397,518
|
Influenza
|
2012
|
NIA
|
2P01AG021600-08A1
|
8600
|
Impact of aging T cell responses to influenza vaccination
|
MCELHANEY, JANET
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$280,349
|
Influenza
|
2012
|
NIAID
|
5U01AI083005-04
|
|
Manipulating natural host immunoregulation via IDO during viral Infection
|
MELLOR, ANDREW
|
GEORGIA HEALTH SCIENCES UNIVERSITY
|
GA
|
$2,544,175
|
Influenza
|
2012
|
NIAID
|
5R01AI089779-02
|
|
Boosting Flu Vaccination without Adjuvant Injection
|
WU, MEI
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$467,323
|
Influenza
|
2012
|
NIDA
|
5R01DA007908-19
|
|
THC impairment of CD4/CD8 T cell-mediated host resistance to HIV and influenza
|
KAMINSKI, NORBERT
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$287,231
|
Influenza
|
2012
|
NIAID
|
5R43AI093035-02
|
|
Development of novel broad-spectrum influenza A inhibitors
|
MCCORMACK, KEN
|
ARISAN THERAPEUTICS, INC.
|
CA
|
$222,059
|
Influenza
|
2012
|
NIAID
|
1R01AI098757-01
|
|
Small molecule inhibitory leads against influenza RdRp
|
WEBB, THOMAS
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$1,108,397
|
Influenza
|
2012
|
NIGMS
|
5U01GM087719-04
|
|
Impacts of Individual and Social Behavior on Influenza Dynamics and Control
|
GALVANI, ALISON
|
YALE UNIVERSITY
|
CT
|
$529,525
|
Influenza
|
2012
|
FIC
|
5D43TW007393-08
|
|
Peru Infectious Diseases Epidemiology Research Training Consortium
|
LESCANO, ANDRES
|
U.S. NAVAL MEDICAL RES CENTER DETACHMENT
|
DC
|
$184,000
|
Influenza
|
2012
|
NIBIB
|
5R01EB009764-04
|
|
Strain Specific Detection of Influenza at the Point-of-Care
|
SOH, HYONGSOK
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$363,377
|
Influenza
|
2012
|
NIEHS
|
5R21ES019825-02
|
|
RNAi Screen in Air Pollutant-Enhanced Influenza Infection
|
KOBZIK, LESTER
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$242,250
|
Influenza
|
2012
|
NIAID
|
5K08AI089940-03
|
|
TRANSMISSION OF OSELTAMIVIR-RESISTANT INFLUENZA A H1N1 VIRUSES IN GUINEA PIGS
|
BOUVIER, NICOLE
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$129,465
|
Influenza
|
2012
|
NHLBI
|
1R01HL113655-01
|
|
Regulation of alveolar epithelial homeostasis in acute lung injury
|
WANG, JIERU
|
NATIONAL JEWISH HEALTH
|
CO
|
$393,902
|
Influenza
|
2012
|
FIC
|
5R01TW008126-05
|
|
Burden of RSV and Influenza Virus in Children in Pakistan
|
ALI, SYED ASAD
|
AGA KHAN UNIVERSITY
|
PAKIST
|
$50,252
|
Influenza
|
2012
|
NIAID
|
5R01AI087657-03
|
|
Regulatory T cell Modulation of Immunity to Mucosal Viral Infections
|
LUND, JENNIFER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$435,600
|
Influenza
|
2012
|
NIAID
|
5R01AI050933-09
|
|
Human & mouse antibodies against influenza virus
|
AIR, GILLIAN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$358,962
|
Influenza
|
2012
|
NIAID
|
5R01AI080624-04
|
|
Modulation of the host response to influenza virus infection: The IKKe Kinase
|
TENOEVER, BENJAMIN
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$407,661
|
Influenza
|
2012
|
NIAID
|
5R01AI079110-03
|
|
Using Chemical Biology to Interfere with the Influenza Virus Life Cycle
|
ROTH, MICHAEL
|
UNIV OF TX SW MED CTR-DALLAS
|
TX
|
$401,105
|
Influenza
|
2012
|
NIAID
|
1R21AI099431-01
|
|
Mucoadhesive Polymers for Sublingual Vaccine Delivery
|
LAWSON, LOUISE
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$188,125
|
Influenza
|
2012
|
NIAID
|
1R21AI099753-01
|
|
Regulating pulmonary inflammation by type I IFN signaling in neutrophils during i
|
SUN, JIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$233,500
|
Influenza
|
2012
|
NIA
|
5R01AG034949-03
|
|
Natural Killer Cell Responses of Aged Mice to Primary Influenza Infection
|
GARDNER, ELIZABETH
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$336,962
|
Influenza
|
2012
|
NIAID
|
1R21AI099575-01
|
|
Nanoengineered virus-mimics as templates for design of a universal influenza A va
|
GILL, HARVINDER
|
TEXAS TECH UNIVERSITY
|
TX
|
$215,097
|
Influenza
|
2012
|
NHLBI
|
5R01HL031197-27
|
|
Mechanisms of ENaC Inhibition by Replicating Influenza Virus: Role of M2 Protein
|
MATALON, SADIS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$379,870
|
Influenza
|
2012
|
NIAID
|
5R21AI096345-02
|
|
Genetic Variants of Human Carboxylesterase 1 Influence the Activation and Antivir
|
MARKOWITZ, JOHN
|
UNIVERSITY OF FLORIDA
|
FL
|
$183,125
|
Influenza
|
2012
|
NIAID
|
5R01AI024541-24
|
|
Receptor Diversity in Recognition of Influenza HA
|
CATON, ANDREW
|
WISTAR INSTITUTE
|
PA
|
$435,917
|
Influenza
|
2012
|
NHLBI
|
5R01HL033391-28
|
|
T Cell Function in Pulmonary Viral Pulmonary Infection and Injury
|
BRACIALE, THOMAS
|
UNIVERSITY OF VIRGINIA
|
VA
|
$372,672
|
Influenza
|
2012
|
NIAID
|
5R01AI079226-04
|
|
The Movement of Influenza Virus In Human Population
|
POEHLING, KATHERINE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$661,144
|
Influenza
|
2012
|
NIAID
|
5U01AI090043-03
|
|
Crossprotective CTL Against Influenza
|
REINHERZ, ELLIS
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$1,136,663
|
Influenza
|
2012
|
NIAID
|
5R01AI084011-03
|
|
Genetic Epidemiology of Life-Threatening Influenza in Children
|
RANDOLPH, ADRIENNE
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$825,593
|
Influenza
|
2012
|
NIAID
|
5F31AI089034-03
|
|
Sex Hormones and the Innate Immune Response to Influenza Infection
|
ROBINSON, DIONNE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$35,832
|
Influenza
|
2012
|
NIAID
|
5R44AI068217-05
|
|
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe
|
LI, WU-BO
|
FUNCTIONAL GENETICS, INC.
|
MD
|
$997,899
|
Influenza
|
2012
|
NIGMS
|
2R01GM080533-06
|
|
The Evolutionary and Biological Bases of Host Switching in Viruses
|
HOLMES, EDWARD
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
PA
|
$297,262
|
Influenza
|
2012
|
NIAID
|
5K01AI073861-04
|
|
Studies on the Epidemiology of H5N1 Influenza Evolution
|
HAN, THOMAS
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$93,040
|
Influenza
|
2012
|
NIAID
|
2R01AI069351-05
|
|
Modeling B Cell Vaccine Responses in Transplant Recipients
|
ZAND, MARTIN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$447,472
|
Influenza
|
2012
|
NIGMS
|
1R01GM098304-01A1
|
|
Understanding fusion peptide mutations in influenza hemagglutinin
|
KASSON, PETER
|
UNIVERSITY OF VIRGINIA
|
VA
|
$284,561
|
Influenza
|
2012
|
NIAID
|
5U01AI095611-02
|
|
Role of Mucosal DC Subsets in the Control of Influenza A Virus Immunity
|
MERAD, MIRIAM
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$350,152
|
Influenza
|
2012
|
NIAID
|
5K08AI079269-05
|
|
Mechanisms of B Cell Responses to a Novel Adjuvant for Influenza Vaccine
|
HONG, DAVID
|
STANFORD UNIVERSITY
|
CA
|
$130,599
|
Influenza
|
2012
|
NIEHS
|
5R01ES013611-07
|
|
Diesel-Induced Alterations of Influenza infectivity
|
JASPERS, ILONA
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$372,042
|
Influenza
|
2012
|
NIAID
|
2R01AI020201-29A1
|
|
The Structure and Function of the Influenza Virus Genome
|
LAMB, ROBERT
|
NORTHWESTERN UNIVERSITY
|
IL
|
$117,976
|
Influenza
|
2012
|
NIAID
|
5R01AI096189-02
|
|
Integrated System for Rapid Detection of Respiratory Pathogens
|
LOCHHEAD, MICHAEL
|
MBIO DIAGNOSTICS, INC.
|
CO
|
$1,004,556
|
Influenza
|
2012
|
NIAID
|
5U01AI089859-03
|
|
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
|
POLAND, GREGORY
|
MAYO CLINIC
|
MN
|
$10,482,503
|
Influenza
|
2012
|
NIAID
|
1R01AI095740-01A1
|
|
Mechanisms of Haemophilus influenzae pathogenesis in the lung
|
AKERLEY, BRIAN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$237,927
|
Influenza
|
2012
|
NIAID
|
1R01AI093637-01A1
|
|
Regulation of pathogen-specific T cell immunity by adenosine generation
|
HOMANN, DIRK
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$355,514
|
Influenza
|
2012
|
NHLBI
|
5R01HL102469-04
|
|
The role of adenosine in the pathogenesis of influenza
|
DAVIS, IAN
|
OHIO STATE UNIVERSITY
|
OH
|
$377,438
|
Influenza
|
2012
|
NIA
|
5R01AG037943-03
|
|
Using the Default Effect to Promote Healthy Behavior
|
CHAPMAN, GRETCHEN
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
NJ
|
$221,260
|
Influenza
|
2012
|
NIAID
|
5R01AI070847-05
|
|
Developing a Paramyxovirus-based H5N1 Vaccine
|
HE, BIAO
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$722,969
|
Influenza
|
2012
|
NIAID
|
5R01AI052203-08
|
|
Dendritic Cell-Associated C-Type Lectins
|
CLARK, EDWARD
|
UNIVERSITY OF WASHINGTON
|
WA
|
$429,243
|
Influenza
|
2012
|
NIAID
|
1R01AI100119-01
|
|
Development of lung T cell responses in infant respiratory immunity
|
FARBER, DONNA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$471,432
|
Influenza
|
2012
|
NIAID
|
1R01AI100110-01
|
|
Overcoming maternal antibody-mediated immunosuppression
|
JACOB, JOSHY
|
EMORY UNIVERSITY
|
GA
|
$503,660
|
Influenza
|
2012
|
NIAID
|
5R01AI076534-04
|
|
CD4 effector contraction in influenza
|
SWAIN, SUSAN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$407,138
|
Influenza
|
2012
|
NIAID
|
5R43AI093018-02
|
|
Rapid, disposable, nucleic acid diagnostic device for multiplexed point of care f
|
CAI, HONG
|
MESA TECH INTERNATIONAL, INC.
|
NM
|
$285,395
|
Influenza
|
2012
|
NIAID
|
5R01AI089541-03
|
|
Point of care microfluidic diagnosis system for rapid and sensitive detection of
|
BERGERON, MICHEL
|
LAVAL UNIVERSITY
|
CANADA
|
$822,875
|
Influenza
|
2012
|
NIAID
|
5R43AI096830-02
|
|
Identification of novel influenza antivirals
|
HENKEL, GREGORY
|
ARISAN THERAPEUTICS, INC.
|
CA
|
$233,415
|
Influenza
|
2012
|
NIAID
|
5R01AI096184-02
|
|
A high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimension
|
YAGER, PAUL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$1,177,234
|
Influenza
|
2012
|
NIAID
|
5R01AI078357-04
|
|
HA Surface Presented Yeast Flu Vaccine and Its Enhancement by CD154 Codisplay
|
YE, KAIMING
|
UNIVERSITY OF ARKANSAS AT FAYETTEVILLE
|
AR
|
$344,196
|
Influenza
|
2012
|
NIAID
|
5R01AI089539-03
|
|
Novel Inhibitors of Viral Replication
|
ROTH, MICHAEL
|
UNIV OF TX SW MED CTR-DALLAS
|
TX
|
$401,105
|
Influenza
|
2012
|
NIAID
|
5K22AI092150-02
|
|
Estimation of Intervention Effects in Influenza Outbreaks
|
LESSLER, JUSTIN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$108,000
|
Influenza
|
2012
|
NHLBI
|
5R01HL095163-04
|
|
Cigarette Smoke and Susceptibility to Influenza Infection
|
JASPERS, ILONA
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$423,490
|
Influenza
|
2012
|
NHLBI
|
5R01HL097141-04
|
|
Neonatal Oxygen and Susceptibility to Respiratory Viral Infections
|
O'REILLY, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$515,106
|
Influenza
|
2012
|
NIAID
|
5R43AI092923-02
|
|
A universal influenza vaccine by dual-domain fusion with a novel carrier protein
|
NI, YAWEI
|
KJ BIOSCIENCES, LLC
|
TX
|
$277,928
|
Influenza
|
2012
|
NCCAM
|
5K24AT003683-07
|
|
Midcareer Investigator Award in Patient-Oriented Research (K24)
|
HIBBERD, PATRICIA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$201,648
|
Influenza
|
2012
|
NIAID
|
5R01AI080672-04
|
|
REGULATION OF INFLUENZA VIRUS INFECTION BY ISG15
|
LENSCHOW, DEBORAH
|
WASHINGTON UNIVERSITY
|
MO
|
$335,195
|
Influenza
|
2012
|
NIA
|
5R01AG039485-02
|
|
Aging, T cell repertoire, and cellular immunity to influenza virus
|
BLACKMAN, MARCIA
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$192,700
|
Influenza
|
2012
|
NIAID
|
5U01AI088654-03
|
|
Epidemiology, transmission, and phylogenetics of influenza in a tropical country
|
HARRIS, EVA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$639,618
|
Influenza
|
2012
|
NIAID
|
5R01AI023007-25
|
|
Correlations: Structure-Dynamics-Function in Channels
|
CROSS, TIMOTHY
|
FLORIDA STATE UNIVERSITY
|
FL
|
$464,676
|
Influenza
|
2012
|
NIEHS
|
5U45ES006178-22
|
|
Hazardous Material Worker Health and Safety Training (U45), Cooperative Agreement
|
BORWEGEN, WILLIAM
|
SEIU EDUCATION AND SUPPORT FUND
|
DC
|
$539,281
|
Influenza
|
2012
|
NIAID
|
5R01AI080669-04
|
|
Fusion Inhibitors of Influenza Virus
|
LUO, MING
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$340,732
|
Influenza
|
2012
|
NIAID
|
1R01AI096305-01A1
|
|
Overcoming Immunosenescence by Nanoparticle-Mediated Activation
|
LEONG, KAM
|
DUKE UNIVERSITY
|
NC
|
$392,500
|
Influenza
|
2012
|
NIGMS
|
5R01GM012592-48
|
|
Ultrafast Processes In Proteins And Other Assemblies
|
HOCHSTRASSER, ROBIN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$288,582
|
Influenza
|
2012
|
NIAID
|
5R44AI077161-03
|
|
Cell Mimic Microarrays for the Multivalent Pathogen Profiling & Characterization
|
GUO, ATHENA
|
MICROSURFACES, INC.
|
TX
|
$364,547
|
Influenza
|
2012
|
NIGMS
|
1R43GM101737-01
|
|
Use of Spray-Drying as a Manufacturing Process for Oral Adenovirus Vaccine
|
PATEL, AMISH
|
PAXVAX, INC.
|
CA
|
$298,464
|
Influenza
|
2012
|
NIAID
|
5R01AI080598-04
|
|
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus
|
KAWAOKA, YOSHIHIRO
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$640,878
|
Influenza
|
2012
|
NHLBI
|
5F32HL099168-03
|
|
IL-1 signaling in epithelial cell recovery from influenza-induced damage
|
SANDERS, CATHERINE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$55,670
|
Influenza
|
2012
|
NIGMS
|
8R00GM103523-04
|
|
In vivo characterization of RNA virus assembly lines with EM tomography
|
LANMAN, JASON
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$221,469
|
Influenza
|
2012
|
NIAID
|
1R43AI096592-01A1
|
|
Respiratory Panel Flow-Strip: a Point-of-Care Molecular Diagnostic Test
|
COONEY, CHRISTOPHER
|
AKONNI BIOSYSTEMS, INC.
|
MD
|
$300,000
|
Influenza
|
2012
|
NIAID
|
2R44AI081467-02
|
|
Point of Care Detection of Respiratory Viruses
|
MOSER, MICHAEL
|
LUCIGEN CORPORATION
|
WI
|
$995,154
|
Influenza
|
2012
|
NIAID
|
5R01AI085568-03
|
|
Long-lived B cell Immunity in the Respiratory Tract
|
BAUMGARTH, NICOLE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$376,004
|
Influenza
|
2012
|
RMAP
|
5R01AI092843-03
|
|
Development of a Universal Influenza Seasonal Vaccine
|
WEINER, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$1,113,078
|
Influenza
|
2012
|
NIGMS
|
5U01GM070694-10
|
|
Synthetic Information Systems for Better Informing Public Health Policymakers
|
EUBANK, STEPHEN
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
VA
|
$774,896
|
Influenza
|
2012
|
NCI
|
8DP1CA174426-03
|
|
Chemically Programmed Immunity
|
BARBAS, CARLOS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$940,005
|
Influenza
|
2012
|
NICHD
|
5K24HD060786-03
|
|
Emerging Trends in Antibiotic Use and Their Impact on Primary Care for Children
|
FINKELSTEIN, JONATHAN
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$189,582
|
Influenza
|
2012
|
NINDS
|
1R01NS075840-01A1
|
|
Influenza, Inflammation, and Parkinson's Disease
|
SMEYNE, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$382,813
|
Influenza
|
2012
|
NHLBI
|
5R01HL069031-11
|
|
Enhancing Collectin Mediated Defense Against Influenza
|
HARTSHORN, KEVAN
|
BOSTON MEDICAL CENTER
|
MA
|
$416,925
|
Influenza
|
2012
|
NIAID
|
5R01AI086133-04
|
|
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I
|
KAJA, MURALI-KRISHNA
|
EMORY UNIVERSITY
|
GA
|
$383,625
|
Influenza
|
2012
|
NIAID
|
1R01AI098339-01A1
|
|
Vaccination strategies to overcome immune deficiencies in neonates
|
ALEXANDER-MILLER, MARTHA
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$623,271
|
Influenza
|
2012
|
NIAID
|
5K23AI087821-03
|
|
Genome-wide genetic variation in the human immune response to influenza vaccines
|
FRANCO, LUIS
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$131,496
|
Influenza
|
2012
|
NIAID
|
5R01AI093625-03
|
|
Leukocyte Signaling in the Elderly and Vaccine Immunogenicity
|
LEWIS, DAVID
|
STANFORD UNIVERSITY
|
CA
|
$396,000
|
Influenza
|
2012
|
NIAID
|
5R01AI075312-04
|
|
Effect of Influenza Infection on Alveolar Macrophage Function
|
METZGER, DENNIS
|
ALBANY MEDICAL COLLEGE
|
NY
|
$392,500
|
Influenza
|
2012
|
NIAID
|
5R01AI077785-04
|
|
The influenza A virus nucleoprotein: structure and function
|
TAO, YIZHI
|
RICE UNIVERSITY
|
TX
|
$365,452
|
Influenza
|
2012
|
NIAID
|
5U01AI082115-04
|
|
Inhaled aerosols for prevention and treatment of respiratory infections
|
CLARKE, ROBERT
|
PULMATRIX
|
MA
|
$283,013
|
Influenza
|
2012
|
NIAID
|
5K22AI093789-02
|
|
Constraints on the evolution of influenza oseltamivir resistance
|
BLOOM, JESSE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$106,162
|
Influenza
|
2012
|
NIA
|
5R01AG040188-02
|
|
T cell immunity to influenza virus in the aged nasal mucosa
|
BAATEN, BAS
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$399,750
|
Influenza
|
2012
|
NIBIB
|
5U01EB012495-03
|
|
Influenza vaccination using a microneedle patch
|
PRAUSNITZ, MARK
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
GA
|
$2,026,290
|
Influenza
|
2012
|
NIAID
|
5R01AI072155-06
|
|
Carbohydrate-based Antiinfective Agents
|
WONG, CHI-HUEY
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$473,750
|
Influenza
|
2012
|
NIAID
|
5R03AI092474-02
|
|
Reagents for the analyses of CMI in the ferret influenza model.
|
DUUS, KAREN
|
ALBANY MEDICAL COLLEGE
|
NY
|
$79,000
|
Influenza
|
2012
|
NIA
|
5R21AG041510-02
|
|
Immunity of aged mice after lifelong repeated live or killed influenza vaccines
|
MURASKO, DONNA
|
DREXEL UNIVERSITY
|
PA
|
$193,125
|
Influenza
|
2012
|
NIGMS
|
5SC1AI098976-02
|
|
Molecular effects of SUMOylation on influenza virus infection: SUMO and NS1
|
ROSAS-ACOSTA, GERMAN
|
UNIVERSITY OF TEXAS EL PASO
|
TX
|
$261,625
|
Influenza
|
2012
|
NIGMS
|
5R01GM100467-02
|
|
Influenza Outbreak Prediction: Applying Data Assimilation Methodology to Make...
|
SHAMAN, JEFFREY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$267,200
|
Influenza
|
2012
|
NIGMS
|
5F32GM097997-02
|
|
Signatures of Immunity on the Antigenic Diversity of Pathogens
|
COBEY, SARAH
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$52,190
|
Influenza
|
2012
|
NIA
|
5K23AG040708-02
|
|
Vitamin D and Immunosenescence in Older Long-Term Care Residents
|
GINDE, ADIT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$141,091
|
Influenza
|
2012
|
OD
|
5K23AG040708-02
|
|
Vitamin D and Immunosenescence in Older Long-Term Care Residents
|
GINDE, ADIT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$73,827
|
Influenza
|
2012
|
NIGMS
|
5R01GM100471-02
|
|
Modeling Anthropogenic Effects in the Spread of Infectious Diseases
|
PERRINGS, CHARLES
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$398,953
|
Influenza
|
2012
|
NIAID
|
5R01AI091786-03
|
|
The Role of IFITM3 in the Anti-viral Host Response
|
BRASS, ABRAHAM
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$415,209
|
Influenza
|
2012
|
NIGMS
|
1R01GM102198-01
|
|
Mapping epistasis in molecular evolution: the influenza nucleoprotein
|
BLOOM, JESSE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$326,861
|
Influenza
|
2012
|
NIGMS
|
1R01GM102546-01
|
|
Determination of Markers of High Pathogenicity in Influenza
|
DLUHY, RICHARD
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$278,464
|
Influenza
|
2012
|
NHLBI
|
1R01HL114907-01
|
|
Contribution of Toll-like Receptors in the Pulmonary Response to Nanoparticles an
|
SABO-ATTWOOD, TARA
|
UNIVERSITY OF FLORIDA
|
FL
|
$326,448
|
Influenza
|
2012
|
NIAID
|
1R01AI101047-01
|
|
Novel Influenza A Nanovaccines for Broad Cross Protection
|
WANG, BAOZHONG
|
EMORY UNIVERSITY
|
GA
|
$553,128
|
Influenza
|
2012
|
NIAID
|
1K25AI100946-01
|
|
Bacterial virulence factors contributing to virus-associated pneumonias
|
SMITH, AMBER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$85,014
|
Influenza
|
2012
|
NIAID
|
1K01AI101010-01
|
|
Epidemiology and modeling of the population dynamics of influenza and antimicrobi
|
GOLDSTEIN, EDWARD
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$125,253
|
Influenza
|
2012
|
NIAID
|
1R21AI101676-01
|
|
NMR-based discovery of influenza hemagglutinin probes
|
CAFFREY, MICHAEL
|
UNIVERSITY OF ILLINOIS
|
IL
|
$239,250
|
Influenza
|
2012
|
NIAID
|
1R03AI101625-01
|
|
Canine Influenza Virus Induction of TNF
|
CASTLEMAN, WILLIAM
|
UNIVERSITY OF FLORIDA
|
FL
|
$70,925
|
Influenza
|
2012
|
NIAID
|
1R03AI101953-01
|
|
IFN-lambda polymorphisms and host response to respiratory viral infections in hum
|
WANG, JIERU
|
NATIONAL JEWISH HEALTH
|
CO
|
$79,250
|
Influenza
|
2012
|
NIGMS
|
4R00GM088484-03
|
|
Regulating Influenza Polymerase Structure and Function by Phosphorylation
|
MEHLE, ANDREW
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$249,000
|
Influenza
|
2012
|
NIAID
|
1R01AI097150-01A1
|
|
Household Studies of Influenza and Other Respiratory Viruses
|
MONTO, ARNOLD
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$480,000
|
Influenza
|
2012
|
NIAID
|
1R01AI097241-01A1
|
|
Foundation Immunogens for Influenza Vaccines
|
WEAVER, ERIC
|
MAYO CLINIC
|
MN
|
$415,384
|
Influenza
|
2012
|
NIAID
|
1U19AI100625-01
|
6156
|
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L
|
HEISE, MARK
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$383,543
|
Influenza
|
2012
|
NIA
|
1R43AG042993-01
|
|
Novel Formulation of Flu Vaccine for the Aged
|
JIANG, JIU
|
DMX, INC.
|
PA
|
$298,738
|
Influenza
|
2012
|
NIAID
|
2R01AI071002-06A1
|
|
Developing Myxovirus Inhibitors with Expanded Pathogen Target Range
|
PLEMPER, RICHARD
|
EMORY UNIVERSITY
|
GA
|
$451,195
|
Influenza
|
2012
|
NHLBI
|
1R01HL108949-01A1
|
|
Mechanisms of impaired neutrophil responses in postinfluenza bacterial pneumonia
|
DENG, JANE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$385,000
|
Influenza
|
2012
|
NIGMS
|
1R01GM099827-01A1
|
|
Computational design of specific binding proteins using Leave-One-Out
|
BYSTROFF, CHRISTOPHER
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$384,309
|
Influenza
|
2012
|
NIAID
|
1R01AI097417-01A1
|
|
Influenza A Virus Infection of Human Nasal Epithelial Cells
|
PEKOSZ, ANDREW
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,000
|
Influenza
|
2012
|
NLM
|
1R01LM011180-01A1
|
|
Improving Network Analysis and Visualization for Infectious Disease Control
|
ABERNETHY, NEIL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$383,931
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8700
|
B Cell Immunity to Influenza
|
GREENBERG, HARRY
|
STANFORD UNIVERSITY
|
CA
|
$332,795
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8701
|
T Cell and General Immune Responses to Influenza
|
DAVIS, MARK
|
STANFORD UNIVERSITY
|
CA
|
$210,932
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8702
|
Single-cell phospho-protein signaling analysis of the response to influenza vacci
|
NOLAN, GARRY
|
STANFORD UNIVERSITY
|
CA
|
$206,102
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8703
|
Measuring the Immunome: Genomic Approaches to B Cell Repertoire
|
QUAKE, STEPHEN
|
STANFORD UNIVERSITY
|
CA
|
$272,569
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8704
|
New Bioinformatics Tools For Analyzing Immunological Data
|
BUTTE, ATUL
|
STANFORD UNIVERSITY
|
CA
|
$127,229
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8705
|
Administrative Core
|
DAVIS, MARK
|
STANFORD UNIVERSITY
|
CA
|
$100,632
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8706
|
Pilot Projects Core
|
DAVIS, MARK
|
STANFORD UNIVERSITY
|
CA
|
$314,055
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8707
|
Clinical Core
|
DEKKER, CORNELIA
|
STANFORD UNIVERSITY
|
CA
|
$876,785
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8708
|
Human Immune Monitoring Core
|
HIRSCHBERG, DAVID
|
STANFORD UNIVERSITY
|
CA
|
$272,399
|
Influenza
|
2012
|
NIAID
|
5U19AI057229-09
|
8709
|
Bioinformatics Core
|
BUTTE, ATUL
|
STANFORD UNIVERSITY
|
CA
|
$101,943
|
Influenza
|
2012
|
NIAID
|
5U54AI065357-08
|
6139
|
T-705 Pyrazine derivative treatment of highly pathogenic arenaviral infections
|
GOWEN, BRIAN
|
UTAH STATE UNIVERSITY
|
UT
|
$304,476
|
Influenza
|
2012
|
NIAID
|
5U19AI083024-04
|
8852
|
Interleukin-10 in acute respiratory virus infection
|
BRACIALE, THOMAS
|
UNIVERSITY OF VIRGINIA
|
VA
|
$283,259
|
Influenza
|
2012
|
NIAID
|
5U19AI083024-04
|
8856
|
Innate Regulation of CD8+ T Cell Effector Activites
|
ENELOW, RICHARD
|
DARTMOUTH COLLEGE
|
NH
|
$459,622
|
Influenza
|
2012
|
NIAID
|
5U19AI083024-04
|
8858
|
Histology
|
SUNG, SUN-SANG
|
UNIVERSITY OF VIRGINIA
|
VA
|
$83,163
|
Influenza
|
2012
|
NIAID
|
5U54AI057157-10
|
5813
|
Fusion Inhibitors of H5N1
|
LUO, MING
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$320,322
|
Influenza
|
2012
|
NIAID
|
5U19AI089987-03
|
7147
|
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$486,806
|
Influenza
|
2012
|
NIAID
|
5U19AI089987-03
|
7148
|
Vaccine Induced Activation of T Follicular Helper Cell Subsets
|
UENO, HIDEKI
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$198,985
|
Influenza
|
2012
|
NIAID
|
5U19AI089987-03
|
7150
|
Systems Biology Approach to Study Influenza Vaccine in Children with Autoimmunity
|
PASCUAL, MARIA
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$419,181
|
Influenza
|
2012
|
NIAID
|
5U19AI089987-03
|
7151
|
Systems Biology in Vaccination Post Autologous Hematopoietic Cell Transplant
|
MERAD, MIRIAM
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$352,903
|
Influenza
|
2012
|
NIAID
|
5U19AI089987-03
|
7156
|
Protein Core
|
ZURAWSKI, GERARD
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$228,590
|
Influenza
|
2012
|
NIAID
|
5U54AI081680-04
|
6278
|
Systems Pathogenomics of Severe Acute Respiratory Virus Infection
|
BARIC, RALPH
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$746,369
|
Influenza
|
2012
|
NIAID
|
5U54AI081680-04
|
6280
|
Systems Biology Approaches to Viral Pathogenesis and Immunity
|
KATZE, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$976,964
|
Influenza
|
2012
|
NIAID
|
5U19AI057319-09
|
8690
|
Human CD8+ and CD4+ T Cells Responses to Influenza Infection and Vaccination
|
TERAJIMA, MASANORI
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$330,945
|
Influenza
|
2012
|
NIAID
|
5U54AI057158-09
|
5678
|
Animal Core
|
PERLIN, DAVID
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$676,051
|
Influenza
|
2012
|
NIAID
|
5U54AI057158-09
|
5713
|
Live, recombinant newcastle disease virus-based vaccine against high pri pathoge
|
PALESE, PETER
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$374,462
|
Influenza
|
2012
|
NIAID
|
5U19AI089992-03
|
7138
|
Immune responses defining efficiency of influenza vaccination
|
SHAW, ALBERT
|
YALE UNIVERSITY
|
CT
|
$796,005
|
Influenza
|
2012
|
NIAID
|
5U19AI083022-04
|
8872
|
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response
|
SHEN, HAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$333,245
|
Influenza
|
2012
|
NIAID
|
5U19AI083022-04
|
8874
|
Regulatory T Cell Activity in Anti-Viral Immunity
|
CATON, ANDREW
|
WISTAR INSTITUTE
|
PA
|
$255,339
|
Influenza
|
2012
|
NIAID
|
5U19AI083022-04
|
8875
|
Regulation of Local B Cell Responses to Influenza Under Conditions of Infection,
|
ERIKSON, JAN
|
WISTAR INSTITUTE
|
PA
|
$255,340
|
Influenza
|
2012
|
NIAID
|
5U19AI083022-04
|
8877
|
Microbiology Core
|
SHEN, HAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$135,633
|
Influenza
|
2012
|
NIAID
|
5P01AI089618-02
|
6248
|
B-cell repertoire analysis in influenza vaccination and infection
|
LIAO, HUA-XIN
|
DUKE UNIVERSITY
|
NC
|
$759,032
|
Influenza
|
2012
|
NIAID
|
5P01AI089618-02
|
6254
|
Electron Microscopy Core
|
GRIGORIEFF, NIKOLAUS
|
BRANDEIS UNIVERSITY
|
MA
|
$254,974
|
Influenza
|
2012
|
NIAID
|
5P01AI089618-02
|
8259
|
Manipulating immunodominance in influenza HA
|
DORMITZER, PHILIP
|
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
|
MA
|
$514,061
|
Influenza
|
2012
|
NIAID
|
5P01AI089618-02
|
8260
|
Structural biology of antibody:antigen complexes
|
HARRISON, STEPHEN
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$254,516
|
Influenza
|
2012
|
NIAID
|
5P01AI089618-02
|
8264
|
Administrative Core
|
HARRISON, STEPHEN
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$128,654
|
Influenza
|
2012
|
NIAID
|
5P01AI089618-02
|
8265
|
Clinical Sample Core
|
DENNY, THOMAS
|
DUKE UNIVERSITY
|
NC
|
$257,278
|
Influenza
|
2012
|
NIAID
|
5U19AI090019-03
|
7077
|
Plasmablast trafficking and antibody response in influenza vaccination
|
GREENBERG, HARRY
|
STANFORD UNIVERSITY
|
CA
|
$472,056
|
Influenza
|
2012
|
NIAID
|
5U19AI090019-03
|
7078
|
T cell responses to H1N1 and a longitudinal study of seasonal flu vaccination
|
DAVIS, MARK
|
STANFORD UNIVERSITY
|
CA
|
$230,155
|
Influenza
|
2012
|
NIAID
|
5U19AI090019-03
|
7079
|
Measuring Influenza and H1N1 vaccine responses in immunodeficient patients
|
UTZ, PAUL
|
STANFORD UNIVERSITY
|
CA
|
$237,311
|
Influenza
|
2012
|
NIAID
|
5U19AI090019-03
|
7081
|
Aalysis of immune receptor diversity and oligoclonality in responses to vaccinati
|
FIRE, ANDREW
|
STANFORD UNIVERSITY
|
CA
|
$303,164
|
Influenza
|
2012
|
NIAID
|
5U19AI057234-09
|
8131
|
Enhancing Vaccine Induced T and B Cell Memory Through DC Targeting
|
SEKALY, RAFICK-PIERRE
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$287,205
|
Influenza
|
2012
|
NIAID
|
5U19AI057234-09
|
8132
|
Eliciting Mucosal Immunity in Humanized Mice
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$368,539
|
Influenza
|
2012
|
NIAID
|
5U19AI057234-09
|
8133
|
Eliciting mucosal immunity in non-human primates
|
LEGRAND, ROGER
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$228,926
|
Influenza
|
2012
|
NIAID
|
5U19AI057234-09
|
8134
|
New DC-targeting Vaccine Constructs and Antibody Reagents
|
ZURAWSKI, GERARD
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$345,379
|
Influenza
|
2012
|
NIAID
|
5U19AI057234-09
|
8138
|
Clinical Core
|
RAMILO, OCTAVIO
|
UNIV OF TX SW MED CTR-DALLAS
|
TX
|
$159,780
|
Influenza
|
2012
|
NIAID
|
5U19AI057234-09
|
8140
|
Immunomonitoring Core
|
UENO, HIDEKI
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$176,812
|
Influenza
|
2012
|
NIAID
|
5U19AI083025-04
|
5043
|
TRIM mediated host antiviral responses during influenza virus infections
|
GARCIA-SASTRE, ADOLFO
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$468,231
|
Influenza
|
2012
|
NIAID
|
5U19AI090023-03
|
7812
|
Systems biological analyses of adaptive responses to vaccination
|
AHMED, RAFI
|
EMORY UNIVERSITY
|
GA
|
$654,924
|
Influenza
|
2012
|
NIAID
|
5U19AI090023-03
|
7814
|
Clinical and Statistical
|
MULLIGAN, MARK
|
EMORY UNIVERSITY
|
GA
|
$802,913
|
Influenza
|
2012
|
NIAID
|
5P01AI046530-13
|
8802
|
Generation and persistence of CD4 memory subsets
|
SWAIN, SUSAN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$370,761
|
Influenza
|
2012
|
NIAID
|
5P01AI046530-13
|
8803
|
CD8 memory T cells: mechanisms of protection
|
DUTTON, RICHARD
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$305,681
|
Influenza
|
2012
|
NIAID
|
5P01AI046530-13
|
8804
|
Regulation of T cell homeostasis and memory
|
BRADLEY, LINDA
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$595,834
|
Influenza
|
2012
|
NIAID
|
5P01AI046530-13
|
8807
|
Joint reagents, mice and viruses
|
DUTTON, RICHARD
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$85,268
|
Influenza
|
2012
|
OD
|
5U19AI067798-08
|
6749
|
Inflammation and Radiation-induced Lung Injury
|
TING, JENNY
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$302,105
|
Influenza
|
2012
|
NIAID
|
5P01AI078897-05
|
0002
|
Visualizing Effects of Costimulation on Antiviral Immunity
|
SHARPE, ARLENE
|
HARVARD UNIVERSITY
|
MA
|
$411,538
|
Influenza
|
2012
|
NIAID
|
5P01AI078897-05
|
0003
|
Complement Receptors in Humoral Immunity to Influenza
|
CARROLL, MICHAEL
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$339,329
|
Influenza
|
2012
|
NICHD
|
2R01HD036520-15
|
|
Molecular Mechanisms of Sleep Responses to Viral Infection
|
KRUEGER, JAMES
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$401,799
|
Influenza
|
2012
|
NIAID
|
1R21AI102169-01
|
|
Host-targeted antivirals for influenza and other respiratory virus infections
|
SHAW, MEGAN
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$211,875
|
Influenza
|
2012
|
NIAID
|
1R21AI102188-01
|
|
Combinations of FDA-Approved Host-Targeted Drugs with Broad Antiviral Activity
|
NGUYEN, JACK
|
ADAMAS PHARMACEUTICALS, INC.
|
CA
|
$337,544
|
Influenza
|
2012
|
NIAID
|
1R21AI102197-01
|
|
NOX1 and NOX2 as Therapeutic Targets in Influenza
|
LAMBETH, JOHN
|
EMORY UNIVERSITY
|
GA
|
$192,808
|
Influenza
|
2012
|
NIAID
|
1R21AI102239-01
|
|
Targeting matrix metalloproteinases to limit immunopathology in airborne infectio
|
ELKINGTON, PAUL
|
UNIVERSITY OF SOUTHAMPTON
|
UK
|
$149,254
|
Influenza
|
2012
|
NIAID
|
1R43AI098253-01A1
|
|
A Novel Cassette System for the Assembly of VLP Vaccines
|
BLACKBURN, MICHAEL
|
SHIFA BIOMEDICAL
|
PA
|
$296,731
|
Influenza
|
2012
|
NIAID
|
2R44AI072861-03A1
|
|
Identification of Novel Broad Spectrum Influenza Virus Inhibitors
|
BASU, ARNAB
|
MICROBIOTIX, INC
|
MA
|
$1,000,000
|
Influenza
|
2012
|
NIAID
|
1R43AI098290-01A1
|
|
Cross-Protective Monoclonal Antibodies for treatment of pandemic Flu
|
CLEGG, CHRISTOPHER
|
TRIA BIOSCIENCE CORPORATION
|
WA
|
$300,000
|
Influenza
|
2012
|
NIA
|
1R43AG043219-01
|
|
The Cotton Rat: Translational Model of Influenza Vaccines for the Elderly
|
BOUKHVALOVA, MARINA
|
SIGMOVIR BIOSYSTEMS, INC.
|
MD
|
$273,222
|
Influenza
|
2012
|
NIAID
|
1R13AI102501-01
|
|
6th Orthomyxovirus Research Conference
|
SCHULTZ-CHERRY, STACEY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$8,000
|
Influenza
|
2012
|
NIA
|
3K23AG040708-01S2
|
|
Vitamin D and Immunosenescence in Older Long-Term Care Residents
|
GINDE, ADIT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$11,604
|
Influenza
|
2012
|
NIAID
|
1P01AI097092-01A1
|
5368
|
Design of New Immunogens Based on Conserved Epitopes in the Influenza Virus...
|
PALESE, PETER
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$324,719
|
Influenza
|
2012
|
NIAID
|
1P01AI097092-01A1
|
5369
|
Generating Long-Lived Protective Immunity Using a Universal Influenza Virus
|
AHMED, RAFI
|
EMORY UNIVERSITY
|
GA
|
$487,066
|
Influenza
|
2012
|
NIAID
|
1P01AI097092-01A1
|
5370
|
In Vivo Evaluation of the Protective Efficacy of HA Immunogens and Antibodies
|
GARCIA-SASTRE, ADOLFO
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$328,073
|
Influenza
|
2012
|
NIAID
|
1P01AI097092-01A1
|
5371
|
Administrative Core
|
PALESE, PETER
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$91,123
|
Influenza
|
2012
|
NIAID
|
1P01AI097092-01A1
|
5372
|
Monoclonal Antibody Technology Core
|
WILSON, PATRICK
|
UNIVERSITY OF CHICAGO
|
IL
|
$497,827
|
Influenza
|
2012
|
NCATS
|
1U18TR000560-01
|
|
3D human lung model to study lung disease and formation of fibrosis
|
NICHOLS, JOAN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$206,357
|
Influenza
|
2012
|
RMAP
|
1U18TR000560-01
|
|
3D human lung model to study lung disease and formation of fibrosis
|
NICHOLS, JOAN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$103,721
|
Influenza
|
2012
|
NIAID
|
5U54AI057159-09
|
5969
|
The In Vivo Relevance and Therapeutic Applications of the IFITM Proteins
|
FARZAN, MICHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$330,112
|
Influenza
|
2012
|
NIAID
|
272200800002C-13-0-3
|
|
Vaccine and Treatment Evaluation Units
|
KEITEL, WENDY
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$668,081
|
|
|